Would you ever consider prophylactic anticoagulation in patients with CKD requiring ESA therapy?
While the CKD population is at high thrombotic and bleeding risk, would you consider anticoagulating a patient prophylactically if they had a history of unprovoked VTE or an inherited thrombophilia?
Answer from: at Academic Institution
I would not start anticoagulation in this setting solely because the patient is to receive ESA treatment, but would advocate for adjusting the ESA dose to maintain a hemoglobin of 9-10 g/dL, since a number of studies suggest that targeting higher hemoglobin levels is associated with increased risk o...
Sign in or Register to read more